Le, T.Y. et al. 2026. FIRST-LINE TREATMENT OUTCOMES OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: SINGLE-CENTER REAL-WORLD DATA FROM VIETNAM, FROM 2020 TO 2026. Journal of Military Pharmaco-medicine. 51, 8 (Aug. 2026), 152–161. DOI:https://doi.org/10.56535/jmpm.v51i8.2085.